{
    "nctId": "NCT05324020",
    "briefTitle": "eHealth Intervention for Medication Adherence in Breast Cancer Survivors",
    "officialTitle": "Improving Oral Hormonal Therapy Adherence in Breast Cancer Survivors by Using eHealth as a New Intervention Tool",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "Acceptability of medication adherence support tool",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* Female aged \u226518 years old\n* 1st prescription of adjuvant treatment (Nolvadex, Arimidex)\n* Treated in either the Centre Hospitalier du Luxembourg (CHL) or Centre Hospitalier Emile Mayrisch (CHEM)\n* Luxembourg resident\n* Fluent in French and/or German\n* Outpatient\n* Possession of a smart-phone (iOS, Android)\n\nExclusion Criteria:\n\n* Male\n* In situ or metastatic tumors\n* Follow-up treatment outside of CHL or CHEM\n* Non-Luxembourgish residents\n* Inpatient",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}